NEW YORK and LONDON, July 06, 2023 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing...
WARREN, N.J., July 06, 2023 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company...
Met all primary endpoints: Vaccine was well-tolerated with robust immunogenicity Continue to expect topline data from Phase 2 GI.1 challenge...
Seasoned HR executive Melinda Kimbro will drive tech-enabled Medicare Advantage company’s people strategy, ensuring organizational excellence and boosting employee experience...
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is very pleased to announce several exciting...
Key study results Key efficacy endpointsEblasakimab is the first biologic in moderate-to-severe atopic dermatitis to demonstrate a competitive efficacy profile...
HORSHAM, Pa., July 06, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to...
Company advances commercialization of Securegard smart safety syringe product linethrough qualification programs with a major medical device company Production of...
OTC Markets symbol change aligns with recent TSX listingTORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the...
Network’s Expansion Across the U.S. and Europe Aims to Advance Translational Genomics ResearchLEXINGTON, Mass., July 06, 2023 (GLOBE NEWSWIRE) --...
CINCINNATI, July 06, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology...